Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer

NCT01017809 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped NYU 03-67 reached accrual prior to this study opening.

Conditions

Interventions

Sponsor

NYU Langone Health